Historical Perspective and Current Trends in Anticancer Drug Development.

Area of Science:

• Oncology and Pharmacology
• Drug Discovery and Development

Background:

• Cancer remains a significant global health challenge and a leading cause of mortality in the 21st century.
• The search for novel anticancer agents is a continuous effort involving natural product isolation and synthetic molecule screening.
• Effective anticancer drug candidates must selectively target cancer cells, inhibiting proliferation or inducing apoptosis while sparing normal cells.

Purpose of the Study:

• To provide a historical overview of the development of major anticancer drug classes.
• To discuss the methodologies employed in the discovery of anticancer compounds.
• To acknowledge the inherent side effects associated with current anticancer therapies.

Main Methods:

• Literature review of historical anticancer drug development.
• Analysis of compound screening and isolation strategies.
• Examination of drug efficacy and toxicity profiles.

Main Results:

• Anticancer drug discovery has evolved significantly over decades.
• Both natural product-derived and synthetic compounds have yielded important anticancer agents.
• A common characteristic across major anticancer drug groups is the presence of significant side effects.

Conclusions:

• The history of anticancer drug development is marked by both serendipitous discoveries and dedicated research.
• Despite advancements, achieving selective cancer cell toxicity without harming healthy tissues remains a key challenge.
• Future research must focus on developing more targeted and less toxic anticancer therapies.